n-formylmethionine leucyl-phenylalanine and Cardiovascular Diseases

n-formylmethionine leucyl-phenylalanine has been researched along with Cardiovascular Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boelaert, J; Dhondt, A; Glorieux, G; Liabeuf, S; Massy, Z; Neirynck, N; Schepers, E; Vanholder, R1
Castelli, P; Castiglioni, L; Consuelo Maio, R; Cosentino, M; De Leo, A; Guasti, L; Lecchini, S; Legnaro, M; Marino, F; Maroni, L; Piffaretti, G; Rasini, E; Schembri, L; Tozzi, M; Venco, A1
Olsen, GD; Videm, V1
Himmelfarb, J; McMonagle, E1

Reviews

1 review(s) available for n-formylmethionine leucyl-phenylalanine and Cardiovascular Diseases

ArticleYear
Manifestations of oxidant stress in uremia.
    Blood purification, 2001, Volume: 19, Issue:2

    Topics: Biomarkers; Blood Proteins; C-Reactive Protein; Cardiovascular Diseases; Dose-Response Relationship, Drug; Elapid Venoms; Humans; Hypochlorous Acid; Inflammation; Kidney Failure, Chronic; Macrophage Activation; N-Formylmethionine Leucyl-Phenylalanine; Oxidation-Reduction; Oxidative Stress; Peroxidase; Phagocytes; Phagocytosis; Renal Dialysis; Sulfhydryl Compounds; Tetradecanoylphorbol Acetate; Uremia

2001

Other Studies

3 other study(ies) available for n-formylmethionine leucyl-phenylalanine and Cardiovascular Diseases

ArticleYear
Uremia-related oxidative stress in leukocytes is not triggered by β2-microglobulin.
    Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2013, Volume: 23, Issue:6

    Topics: beta 2-Microglobulin; Biomarkers; Cardiovascular Diseases; Escherichia coli; Humans; Leukocytes; N-Formylmethionine Leucyl-Phenylalanine; Oxidative Stress; Phorbol Esters; Renal Insufficiency, Chronic; Respiratory Burst; Uremia

2013
Angiotensin type 1 receptor expression and interleukin-8 production in polymorphonuclear leukocytes of patients with peripheral arterial disease.
    Journal of cardiovascular pharmacology, 2009, Volume: 54, Issue:6

    Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Apolipoproteins A; Apolipoproteins B; Atherosclerosis; Atorvastatin; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Endarterectomy; Female; Femoral Artery; Gene Expression; Heptanoic Acids; Humans; Interleukin-8; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peripheral Vascular Diseases; Pyrroles; Receptor, Angiotensin, Type 1; Triglycerides

2009
No relationship between neutrophil granulocyte activation and the myeloperoxidase gene - 129 G>A and - 463 G>A promoter polymorphisms: implications for investigations of cardiovascular disease.
    Coronary artery disease, 2009, Volume: 20, Issue:7

    Topics: Cardiovascular Diseases; Cell Degranulation; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Gene Frequency; Genetic Predisposition to Disease; Humans; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Peroxidase; Phenotype; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Reactive Oxygen Species; Risk Assessment; Risk Factors; Tetradecanoylphorbol Acetate

2009